SOURCE: Wall Street Equity Research

Wall Street Equity Research

November 19, 2010 08:09 ET

Professional Research on Adamis Pharmaceuticals Corp. and Emisphere Technologies Inc. - Drug Delivery Companies Looking to Research and Development

JOHANNESBURG, SOUTH AFRICA--(Marketwire - November 19, 2010) - gives shareholders valuable insight on drug delivery stocks Adamis Pharmaceuticals Corp. (OTCBB: ADMP) and Emisphere Technologies Inc. (OTCBB: EMIS). Sign up today at to receive free research reports on these equities.

Companies involved in drug development have been investing heavily in research and development, in hopes of coming up with safe effective treatments for today's diseases or health complications. Researchers are looking into treatments for cancer, hepatitis C, and osteoarthritis, to name a few. While this research sometimes pays off, the nature of the industry requires large amounts of capital upfront, with returns on investments taking years to come or never materializing at all. It is thus essential to secure money in advance in order to succeed. is a specialized website where investors can have specific access to free reports drug delivery industry; traders looking for analyst opinions on Adamis Pharmaceuticals Corp., Emisphere Technologies Inc. and other companies in this industry are welcomed to sign up for a free one year membership at

One company that has had recent funding success is Adamis Pharmaceuticals Corp. The company has recently announced that Eses Holdings Limited has agreed to invest $10 million dollars through common stock purchase. Adamis is currently involved in developing cancer vaccines, as well as preventative and therapeutic products for Hepatitis B and C. Traders can get direct and free access to today's full report on Adamis Pharmaceuticals Corp. by signing up at

Another company working in research and development is Emisphere Technologies Inc. The company is involved in creating oral treatments for health problems such as osteoarthritis and type-2 diabetes. The company is also working on a formulation that delivers vitamin B12 more efficiently. Traders can have complimentary access to today's complete research report on Emisphere Technologies Inc. by signing up at

Visit us at to understand the catalysts and forces driving or affecting the drug delivery industry in today's economic environment.

About Wall Street Equity Research: 

Wall Street Equity Research looks to bring simplicity and highly sophisticated research to an ever-changing investing environment. Wall Street Equity Research has been partnering with a number of North American and Emerging Economies analysts to bring you the best of both continents in terms of market analysis and analytical opinions. 

Contact Information